Inventor
BENHAR ITAI
IL19 patents
⚠️ This page may combine multiple inventors who share the name “BENHAR ITAI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV RAMOT
8 patentsUS8043621B2Oct 25, 2011
Recombinant fusion protein and polynucleotide construct for immunotoxin production
UNIV RAMOT10 citations83
US7985573B2Jul 26, 2011
Targeted drug-carrying bacteriophages
UNIV RAMOT16 citations79
US11708421B2Jul 25, 2023
Modular platform for targeted therapeutics
UNIV RAMOT1 citations55
US8741598B2Jun 3, 2014
Photocatalytic hydrogen production in cyanobacteria
UNIV RAMOT0 citations50
US8039594B2Oct 18, 2011
Human synthetic single-chain antibodies directed against the common epitope of mutant P53 and their uses
UNIV RAMOT1 citations46
US12509512B2Dec 30, 2025
Semaphorin 3A antibodies and uses thereof
UNIV RAMOT0 citations45
US10822428B2Nov 3, 2020
Bi-and monospecific, asymmetric antibodies and methods of generating the same
UNIV RAMOT0 citations43
US9925275B2Mar 27, 2018
Amphotericin B derivatives
UNIV RAMOT0 citations41
US HEALTH
3 patentsUS5889157AMar 30, 1999
Humanized B3 antibody fragments, fusion proteins, and uses thereof
US HEALTH64 citations95
US5981726ANov 9, 1999
Chimeric and mutationally stabilized tumor-specific B1, B3 and B5 antibody fragments; immunotoxic fusion proteins; and uses thereof
US HEALTH40 citations92
US6287562B1Sep 11, 2001
Methods of inhibiting the growth of cells bearing LewisY antigens using B1, B3, or B5 targeted immunoconjugates
US HEALTH9 citations73
BENHAR ITAI
3 patentsUS8329183B2Dec 11, 2012
Recombinant fusion protein and polynucleotide construct for immunotoxin production
BENHAR ITAI0 citations48
US9321847B2Apr 26, 2016
Activatable toxin complexes comprising a cleavable inhibitory peptide
BENHAR ITAI2 citations47
US9624291B2Apr 18, 2017
Bi- and monospecific, asymmetric antibodies and methods of generating the same
BENHAR ITAI0 citations41